Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2023-05-05 00:00:00 ET · period of report 2023-05-04 · accession 0000899243-23-012353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-05 | 2023-05-04 | KPTI | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $3.35 | -3,805 | 812.8K | -0.5% | -$12.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-04 | S | D | 3,805 | $3.35 | 812,814 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.35 to $3.37, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |